Facult� de m�decine et des sciences de la sant�


Roux S, Chamoux E.

Osteoclast apoptosis.
New Cell Apoptosis Research, 2007 Jan 1; 163-184.

Roux S.

RANKL inhibitors: a bright future?
Joint Bone Spine, 2006 Mar 1; 73(2):129-31.

Roux S, Lambert-Comeau P, Saint-Pierre C, Lepine M, Sawan B, Parent JL.

Death receptors, Fas and TRAIL receptors, are involved in human osteoclast apoptosis.
Biochemical and Biophysical Research Communications, 2005 Jul 22; 333(1):42-50.

Roux S, Mariette X.

The high rate of bone resorption in multiple myeloma is due to RANK (receptor activator of nuclear factor-kappaB) and RANK Ligand expression.
Leuk Lymphoma, 2004 Jun 1; 45(6):1111-8.

Geoffroy V, Marty-Morieux C, Le Goupil N, Clement-Lacroix P, Terraz C, Frain M, Roux S, Rossert J, de Vernejoul MC.

In vivo inhibition of osteoblastic metalloproteinases leads to increades trabecular bone mass.
Journal of Bone and Mineral Research, 2004 May 1; 19(5):811-22.